Is Greenbrook Tms Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: GBNH) stock is to Buy GBNH stock.
Out of 2 analysts, 1 (50%) are recommending GBNH as a Strong Buy, 0 (0%) are recommending GBNH as a Buy, 1 (50%) are recommending GBNH as a Hold, 0 (0%) are recommending GBNH as a Sell, and 0 (0%) are recommending GBNH as a Strong Sell.
What is GBNH's forecast return on equity (ROE) for 2023-2023?
(NASDAQ: GBNH) forecast ROE is N/A, which is considered weak.
What is GBNH's Price Target?
According to 2 Wall Street analysts that have issued a 1 year GBNH price target, the average GBNH price target is $1.88, with the highest GBNH stock price forecast at $3.00 and the lowest GBNH stock price forecast at $0.75.
On average, Wall Street analysts predict that Greenbrook Tms's share price could reach $1.88 by Apr 19, 2024. The average Greenbrook Tms stock price prediction forecasts a potential upside of 589.34% from the current GBNH share price of $0.27.
What is GBNH's forecast return on assets (ROA) for 2023-2023?
(NASDAQ: GBNH) forecast ROA is -21.54%, which is lower than the forecast US Medical Care Facilities industry average of 7.02%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.